Overview

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Status:
Suspended

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.

Phase:

Phase 2

Details

Lead Sponsor:

US WorldMeds LLC

Treatments:

Analgesics, Opioid
Clonidine
Lofexidine